Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00334
|
|||||
Drug Name |
Valinomycin
|
|||||
Synonyms |
Antibiotic N-329 B; Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); Potassium ionophore I; UNII-N561YS75MN; Valinomicin; cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3; valino; valinomycin
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
Therapeutic Class |
Antibiotics
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C54H90N6O18
|
|||||
Canonical SMILES |
CC1C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)O1)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C
|
|||||
InChI |
InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)/t31-,32-,33-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m0/s1
|
|||||
InChIKey |
FCFNRCROJUBPLU-DNDCDFAISA-N
|
|||||
CAS Number |
CAS 2001-95-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 1111.3 | Topological Polar Surface Area | 332 | ||
Heavy Atom Count | 78 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 18 | |||
XLogP |
9.1
|
|||||
PubChem CID | ||||||
ChEBI ID |
ChEBI:28545
|
|||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [1] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | P-GP | Transporter Info | Km = 1 microM | Chinese hamster ovary AA8 cells-MDR1 | [2] | |
P-GP | Transporter Info | Km = 2.5 microM | Spodoptera frugiperda (Sf9) cells-MDR1 | [1] | ||
References | ||||||
1 | Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J. 2007 Jan 15;401(2):597-605. | |||||
2 | Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 1996 Feb 9;271(6):3163-71. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.